Morgan Stanley Sticks to Their Hold Rating for Atlas Arteria (MAQAF)
I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst Robert Koh maintained a Hold rating on Atlas Arteria (MAQAF) with a price target of A$4.66. This follows a similar Hold from Morgans' Nathan Lead, while RBC Capital previously issued a Sell rating on July 16.
In a report released today, Robert Koh from Morgan Stanley maintained a Hold rating on Atlas Arteria, with a price target of A$4.66.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Koh covers the Energy sector, focusing on stocks such as Viva Energy Group Ltd., Santos Limited, and Beach Energy . According to TipRanks, Koh has an average return of 0.2% and a 56.35% success rate on recommended stocks.
In addition to Morgan Stanley, Atlas Arteria also received a Hold from Morgans’s Nathan Lead in a report issued today. However, on July 16, RBC Capital maintained a Sell rating on Atlas Arteria (Other OTC: MAQAF).